Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Immunotherapy, Adoptive × 30 days × Clear all

Phase

Phase NA 3 Phase 1 3 Phase EARLY_PHASE1 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Specimen Handling 4 Biopsy 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Bevacizumab 3 tremelimumab 2 olaparib 2 encorafenib 2 X-Rays 2 Panitumumab 2 Nivolumab 2 Immunoglobulin G 2 Folfox protocol 2 Disulfides 2 Cyclophosphamide 2 Cetuximab 2 Aminolevulinic Acid 2 ulixertinib 1 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tipiracil 1 sotorasib 1 senicapoc 1 romiplostim 1 pirtobrutinib 1 perflutren 1 perampanel 1 onvansertib 1 niraparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07458659 2026-03-09

CART-BCMA

Chulalongkorn University

Phase EARLY_PHASE1 Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡